Smith And Nephew Plc Revenue Growth Rates (SNN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Smith and Nephew Plc  (NYSE: SNN)
 

SNN's Revenue Growth by Quarter and Year

Smith And Nephew Plc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNN Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 6,164.00
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 6,164.00

SNNs Annual Revenue
Smith And Nephew Plc's Revenue in the fiscal year 2025 $ 6,164.00 millions
Smith And Nephew Plc's Revenue in the fiscal year 2024 $ 5,810.00 millions
Smith And Nephew Plc's Revenue in the fiscal year 2023 $ 5,549.00 millions
Smith And Nephew Plc's Revenue in the fiscal year 2022 $ 0.00 millions
Smith And Nephew Plc's Revenue in the fiscal year 2021 $ 5,221.00 millions




SNN Revenue fourth quarter 2025 Y/Y Growth Comment
Smith And Nephew Plc showed record Revenue improvement in the fourth quarter 2025 with 6.09% from the fourth quarter 2025 2024, to $ 6,164.00 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 78 other companies have achieved higher Revenue growth. While Smith And Nephew Plc' s Revenue increase of 6.09% ranks overall at the positon no. 1632 in the fourth quarter 2025.


SNN Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 6.09 % 4.7 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   6.09 % 4.7 % - -

Financial Statements
Smith And Nephew Plc's fourth quarter 2025 Revenue $ 6,164.00 millions SNN's Income Statement
Smith And Nephew Plc's fourth quarter 2024 Revenue $ 5,810.00 millions Quarterly SNN's Income Statement


SNN Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   6.09 % 4.7 % - -


Back to SNN Growth rate Comparisons >> Back to SNN Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #264
Overall #1632

Revenue Y/Y Growth Statistics
High Average Low
6.09 % 5.4 % 4.7 %
 
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #264
Overall #1632
Revenue Y/Y Growth Statistics
High Average Low
6.09 % 5.4 % 4.7 %
 

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Smith And Nephew Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SNN's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SNN's IV. Quarter Q/Q Revenue Comment


Smith And Nephew Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 6,164.00 $ 5,810.00 $ 5,549.00 $ 0.00 $ 5,221.00
Y / Y Revenue Growth (TTM) 6.09 % 4.7 % - - -
Year on Year Revenue Growth Overall Ranking # 2048 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 6.09 % 4.7 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2048 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 6.09% annual Revenue growth, Smith And Nephew Plc would report a record annual Revenue improvement if the fiscal year would end on Dec 31 2025.

In the Healthcare sector 312 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2048.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 313
Overall # 2048

Revenue TTM Y/Y Growth Statistics
High Average Low
6.09 %
 5.4 %
4.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 111
Sector # 313
S&P 500 # 2048
Cumulative Revenue growth Comment
With 6.09% annual Revenue growth, Smith And Nephew Plc would report a record annual Revenue improvement if the fiscal year would end on Dec 31 2025.

In the Healthcare sector 312 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2048.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 313
Overall # 2048

Revenue TTM Y/Y Growth Statistics
High Average Low
6.09 %
5.4 %
4.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 111
Sector # 313
S&P 500 # 2048




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SNN's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Iqvia Holdings Inc 10.26%$ 10.258 millions
Biotricity Inc 10.19%$ 10.188 millions
Jazz Pharmaceuticals Plc10.09%$ 10.086 millions
Abbvie Inc 10.04%$ 10.038 millions
Encompass Health Corporation9.94%$ 9.936 millions
Davita Inc 9.87%$ 9.868 millions
Bausch and Lomb Corp9.77%$ 9.766 millions
Enanta Pharmaceuticals Inc9.76%$ 9.765 millions
Aquestive Therapeutics Inc 9.67%$ 9.674 millions
Zomedica Corp 9.67%$ 9.667 millions
Novartis Ag9.57%$ 9.574 millions
Vertex Pharmaceuticals Inc9.55%$ 9.547 millions
Procept Biorobotics Corporation9.53%$ 9.532 millions
Acadia Pharmaceuticals Inc 9.39%$ 9.394 millions
Bausch Health Companies Inc 9.26%$ 9.261 millions
Cuprina Holdings cayman Limited9.20%$ 9.197 millions
Burning Rock Biotech Limited9.18%$ 9.184 millions
Steris Plc9.17%$ 9.166 millions
Johnson and Johnson9.08%$ 9.076 millions
Universal Health Services Inc 9.05%$ 9.051 millions
Upstream Bio Inc 8.97%$ 8.972 millions
Tenet Healthcare Corp8.97%$ 8.971 millions
Fresenius Medical Care Ag8.77%$ 8.771 millions
Option Care Health Inc 8.63%$ 8.631 millions
Astrazeneca Plc8.63%$ 8.629 millions
Amgen Inc 8.58%$ 8.585 millions
Integer Holdings Corporation8.38%$ 8.377 millions
Vivosim Labs Inc 8.33%$ 8.333 millions
China Pharma Holdings Inc8.11%$ 8.113 millions
Novocure Limited8.11%$ 8.113 millions


About Smith And Nephew Plc Revenue Growth Rates (SNN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Smith and Nephew Plc (CIK 845982).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-028258
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Smith and Nephew Plc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.